Market Insights Health Pharmaceuticals Vaccines

COVID-19 Vaccines - Ireland

Ireland

In Ireland, the projected revenue in the COVID-19 Vaccines market for the year 2024 is estimated to reach US$19.06m.
Looking ahead, the market is expected to exhibit a robust annual growth rate (CAGR 2024-2028) of -21.25%.
This growth trajectory is anticipated to result in a market volume of US$7.33m by the year 2028.
When comparing revenue on a global scale, it is noteworthy that United States is projected to generate the highest amount, with an estimated revenue of US$1,832,000.00k in 2024.
Ireland is witnessing a growing demand for COVID-19 vaccines, with an increasing focus on ensuring equitable distribution across all regions.

Key regions: Japan, Italy, China, South Korea, Brazil

Market

Region

Region comparison

Currency

Analyst Opinion

The COVID-19 pandemic has brought about a surge in the demand for vaccines worldwide, and Ireland is no exception. The country has been actively participating in the vaccination drive and has been witnessing a steady increase in the number of people getting vaccinated.

Customer preferences: The Irish population has shown a keen interest in getting vaccinated against COVID-19. The government has been actively promoting the vaccination drive, and the citizens have been responding positively to it. The preference for vaccines has been high, and people have been showing a willingness to get vaccinated as soon as possible.

Trends in the market: The COVID-19 vaccine market in Ireland has been witnessing a steady growth with the government procuring vaccines from various manufacturers. The vaccination drive has been progressing at a steady pace, and the number of people getting vaccinated has been increasing. The market has been dominated by Pfizer-BioNTech and Moderna, with AstraZeneca and Johnson & Johnson vaccines also being administered. The demand for vaccines has been high, and the government has been actively procuring more vaccines to meet the demand.

Local special circumstances: Ireland has been facing certain challenges in the vaccination drive due to the limited availability of vaccines. The government has been procuring vaccines from various manufacturers, but the supply has not been consistent. The country has also been facing challenges in terms of the distribution and administration of vaccines due to the limited healthcare infrastructure. However, the government has been taking steps to address these challenges and has been working towards ensuring a smooth vaccination drive.

Underlying macroeconomic factors: The COVID-19 pandemic has had a significant impact on the Irish economy, with many businesses facing closures and job losses. The vaccination drive is seen as a crucial step towards reviving the economy, and the government has been actively promoting it. The success of the vaccination drive is expected to have a positive impact on the economy, with businesses reopening and people returning to work. The government has also been providing financial support to businesses and individuals affected by the pandemic, which has been helping to mitigate the economic impact of the pandemic.In conclusion, the COVID-19 vaccine market in Ireland has been witnessing a steady growth, with the government procuring vaccines from various manufacturers. The demand for vaccines has been high, and people have been showing a keen interest in getting vaccinated. While there have been certain challenges in the vaccination drive, the government has been taking steps to address them and ensure a smooth vaccination drive. The success of the vaccination drive is expected to have a positive impact on the Irish economy, which has been severely impacted by the pandemic.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.

Modeling approach / Market size:

Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.